A new testing strategy to identify rare variants with either risk or protective effect on disease.
Rapid advances in sequencing technologies set the stage for the large-scale medical sequencing efforts to be performed in the near future, with the goal of assessing the importance of rare variants in complex diseases. The discovery of new disease susceptibility genes requires powerful statistical m...
Main Authors: | Iuliana Ionita-Laza, Joseph D Buxbaum, Nan M Laird, Christoph Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-02-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3033379?pdf=render |
Similar Items
-
Rare variant analysis for family-based design.
by: Gourab De, et al.
Published: (2013-01-01) -
Integrative analysis of functional genomic annotations and sequencing data to identify rare causal variants via hierarchical modeling
by: Marinela eCapanu, et al.
Published: (2015-05-01) -
Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autism.
by: Iuliana Ionita-Laza, et al.
Published: (2014-12-01) -
On quality control measures in genome-wide association studies: a test to assess the genotyping quality of individual probands in family-based association studies and an application to the HapMap data.
by: David W Fardo, et al.
Published: (2009-07-01) -
A genome-wide scan statistic framework for whole-genome sequence data analysis
by: Zihuai He, et al.
Published: (2019-07-01)